Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

This study has been completed.
HIV Vaccine Trials Network
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: December 2, 2008
Last updated: June 20, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2015
  Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)